Sun Pharma Advanced Research Company has received approval from the US health regulator for its New Drug Application (NDA) for ELEPSIA XR tablets used for treatment of partial onset seizures in patients with epilepsy. "The US Food and Drug Administration (FDA) has approved New Drug Application (NDA) for ELEPSIA XRTM (Levetiracetam extended-release tablets 1,000 mg and 1,500 mg)," Sun Pharma Advanced Research Company (SPARC) said in a statement. ELEPSIA XR is indicated for adjunctive therapy in the treatment of partial onset seizures in patients of 12 years of age and older with epilepsy, it added. Commenting on the development, SPARC CEO Anil Raghavan said: "Levetiracetam is a very successful and highly effective antiepileptic drug but more than 80% of epilepsy patients require Levetiracetam in doses in range of 1,000 mg to 3,000 mg, resulting in a significant pill burden. "Approval of ELEPSIA XRTM as 1,000 mg and 1,500 mg once a day tablets will be very useful for these patients and physicians." The product will be manufactured by Sun Pharmaceutical Industries at its Halol facility in Gujarat, SPARC said. Sun Pharma Advanced Research Company shares were trading 7.01 per cent up at Rs 440.60 per scrip during afternoon trade on … Continue reading →

WASHINGTON, D.C. (PRWEB) March 04, 2015 With an estimated 1 in 68 American children affected by Autism Spectrum Disorders (ASD), the prevalence has increased ten-fold in the past 40 years. RoboKind, the world leader in social robotics, today unveiled pioneering research results at a National Press Club Newsmakers news conference demonstrating that its humanoid robot Milo increases engagement in children with autism while enhancing the development of social and emotional skills. A leading expert on autism therapy and intervention programs, Dr. Pamela Rollins, MS, Ed.D., associate professor of Communication Disorders at the University of Texas at Dallas, presented preliminary research that indicates children who interact with social robots are more engaged in autism therapy compared to interactions with humans. By helping children with ASD identify emotions and specific social interactions, they are better able to achieve academic and personal success. Dr. Rollins teaches graduate-level courses on the assessment and treatment of children and ASD at the Callier Center for Communication Disorders. She has more than 30 years of experience researching, teaching and clinically practicing with children on the autism spectrum. Ive witnessed children who struggle with social situations immediately connect with Milo and reveal skills they had never before exhibited … Continue reading →

State of stroke treatment in Kenya Medical experts are now expressing concerns over the high number of people who continue to suffer in silence unaware they are suffering from stroke.Dr. Samue... By: Kbc Kenya … Continue reading →